Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation [NA]

View source ↗

Summary

Clinical trial results update examining the effects of lubiprostone on gastrointestinal transit and pH in irritable bowel syndrome with constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitiza (lubiprostone)

Snippet

Sponsor: University of Michigan | Conditions: Irritable Bowel Syndrome, Constipation | NA | Status: COMPLETED | Results posted: 2017-01-27